Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG | Zendy

Anahid Ehteda | Zendy; Sandy Simon | Zendy; Laura Franshaw | Zendy; Federico M. Giorgi | Zendy; Jie Liu | Zendy; Swapna Joshi | Zendy; Jourdin R.C. Rouaen | Zendy; Chi Nam Ignatius Pang | Zendy; Ruby Pandher | Zendy; Chelsea Mayoh | Zendy; Yujie Tang | Zendy; Aaminah Khan | Zendy; Caitlin Ung | Zendy; Ornella Tolhurst | Zendy; Anne Kankean | Zendy; Elisha Hayden | Zendy; Rebecca Lehmann | Zendy; Sylvie Shen | Zendy; Anjana Gopalakrishnan | Zendy; Peter Trebilcock | Zendy; Katerina V. Gurova | Zendy; Andrei V. Gudkov | Zendy; Murray D. Norris | Zendy; Michelle Haber | Zendy; Orazio Vittorio | Zendy; Maria Tsoli | Zendy; David S. Ziegler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG

Author(s) -

Anahid Ehteda,

Sandy Simon,

Laura Franshaw,

Federico M. Giorgi,

Jie Liu,

Swapna Joshi,

Jourdin R.C. Rouaen,

Chi Nam Ignatius Pang,

Ruby Pandher,

Chelsea Mayoh,

Yujie Tang,

Aaminah Khan,

Caitlin Ung,

Ornella Tolhurst,

Anne Kankean,

Elisha Hayden,

Rebecca Lehmann,

Sylvie Shen,

Anjana Gopalakrishnan,

Peter Trebilcock,

Katerina V. Gurova,

Andrei V. Gudkov,

Murray D. Norris,

Michelle Haber,

Orazio Vittorio,

Maria Tsoli,

David S. Ziegler

Publication year - 2021

Publication title -

cell reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.264

H-Index - 154

eISSN - 2639-1856

pISSN - 2211-1247

DOI - 10.1016/j.celrep.2021.108994

Subject(s) - panobinostat , histone deacetylase , epigenome , cancer research , histone , chromatin remodeling , histone deacetylase inhibitor , ezh2 , biology , histone h3 , histone deacetylase 5 , chromatin , epigenetics , dna methylation , genetics , dna , gene expression , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research